Chronic Pain Patients Suffering from Opioid Rx Crackdown
the Psychiatry Advisor take:
Legitimate chronic pain patients not being able to get the medications they need to function on a daily basis may be an increasing, unintended consequence of recent crackdowns on prescription opioid abuse, according to a report on Medpage Today.
They profiled Chris Young, a patient with chronic pain from a spinal injury that resulted when a car he was repairing fell on him, and his pharmacist Bill Napier, both of Florida, and several other pain patients and doctors -- detailing the frustration both legitimate patients and ethically sound healthcare providers are experiencing in the wake of regulatory efforts to control the trafficking of illegal prescription narcotics.
In the past several years, Florida alone has shut down more than 250 "pill mills," or clinics were doctors were selling narcotics directly to people for cash, according to Medpage Today. Although law enforcement officials and federal Drug Enforcement Administration (DEA) agents have been successful at closing those types of clinics, in Florida legitimate doctors are no longer able to administer narcotics directly to patients and prescription narcotic wholesalers, who have had to pay settlement claims in lawsuits, are now limiting the amount of medication they're selling to pharmacies.
Healthcare providers are warning that they're being asked to ration medications without a scientific basis, and patients with true chronic pain problems are complaining that they are being treated like addicts.
The chorus of complaints from patients and doctors alike has reached the Florida Board of Pharmacy, the entity responsible for licensing pharmacists and educating them on safe medication practices, which recently hosted a public meeting on the topic. You can read more about this emerging problem on Medpage Today.
Report details patient, healthcare provider frustration in the wake of regulatory efforts to control opioid abuse.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Cognitive Impairment May Predict Persistent Psychosis in Ketamine Users
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders